September 25, 2016 6:05 AM ET

Capital Markets

Company Overview of Sofinnova Ventures, Inc.

Company Overview

Sofinnova Ventures, Inc. is a venture capital firm specializing in seed, startup, early stage, series A, first venture round, and corporate spinouts. It also considers investments in intermediate and later stage startup companies. The firm does not invest in healthcare services, tool-kit companies, diagnostics, and neutraceuticals. It seeks to invest in life sciences and information technology sectors. In life sciences sector, it seeks to invest in clinical stage pharmaceutical products companies, biotechnology, biopharmaceutical, therapeutic drug or product companies in the late preclinical or Phase I clinical stage, drug companies to treat diseases with unmet medical needs, drug discovery ...

3000 Sand Hill Road

Building 4

Suite 250

Menlo Park, CA 94025

United States

Founded in 1974

Phone:

650-681-8420

Fax:

650-322-2037

Key Executives for Sofinnova Ventures, Inc.

Founding Partner
Founder and Managing Partner
Age: 41
General Partner, Managing Partner, and Partner
Age: 51
General Partner and Managing General Partner
Age: 61
Chief Financial Officer and Partner
Compensation as of Fiscal Year 2016.

Sofinnova Ventures, Inc. Key Developments

Sofinnova Ventures, Inc. Presents at BioEquity Europe 2016 Conference, May-10-2016 through May-11-2016

Sofinnova Ventures, Inc. Presents at BioEquity Europe 2016 Conference, May-10-2016 through May-11-2016. Venue: Scandic Hotel, Vester Soegade 6, 1601 Copenhagen, Denmark. Presentation Date & Speakers: May-10-2016, Antoine Papiernik, Managing Partner, James I. Healy, General Partner, Managing Partner, and Partner.

Sofinnova Ventures, Inc. Presents at 13th Annual BIO Asia International Conference 2016, Mar-15-2016

Sofinnova Ventures, Inc. Presents at 13th Annual BIO Asia International Conference 2016, Mar-15-2016 . Venue: Grand Hyatt, Tokyo, Japan.

Sofinnova Ventures, Inc. Presents at Sofinnova Japan Biopharma Partnering Conference 2015, Oct-27-2015 02:05 PM

Sofinnova Ventures, Inc. Presents at Sofinnova Japan Biopharma Partnering Conference 2015, Oct-27-2015 02:05 PM. Venue: Conrad Hotel, 1-9-1, Higashi-Shinbashi, Minato-Ku, Tokyo, 105 7337, Japan. Speakers: Michael F. Powell, General Partner.

Similar Private Companies By Industry

Company Name Region
@Visory LLC United States
1 Road Partners LLC United States
11T Partners, LLC United States
123Jump.com, Inc. United States
1509225 Ontario, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
March 15, 2016
Alvine Pharmaceuticals, Inc.
Private Placement
December 29, 2015
NextCure, Inc.
Private Placement
November 23, 2015
ObsEva SA
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sofinnova Ventures, Inc., please visit www.sofinnova.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.